Evidence map›Paper›PMID 42605989›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

A Dual GSH/ROS-Functional NIR Fluorescent Platform for Synergistic Photodynamic Therapy and Radiosensitization in Nasopharyngeal Carcinoma.

Fan Zheng, Yan Mo, Jin Zhou, Chengmin Li, Min Lin, Yingqi Zhao, Jingmei Zhou, Hui Zou, Zhikang Chen, Runsha Xiao and 2 more

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fan ZhengDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Yan MoDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Jin ZhouNational Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.
Chengmin LiNational Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.ORCID 0009-0004-0762-5369
Min LinNational Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.
Yingqi ZhaoNational Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.
Jingmei ZhouDepartment of Clinical Medicine, Medical College of Xiangya, Central South University, Changsha, China.ORCID 0000-0003-0716-8538
Hui ZouKey Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Health Science Center, Hunan Normal University, Changsha, China.
Zhikang ChenDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Runsha XiaoDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Xueping FengDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China.ORCID 0000-0003-0481-3853
Wenbin ZengXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.ORCID 0000-0001-8314-9174

Funding

Natural Science Foundation of China 82273486Natural Science Foundation of China 82572300Science and Technology Foundation of Hunan Province 2022JJ80052
6 · The paper itself

Abstract

High-precision tumor theranostic systems capable of real time monitoring are imperatively required for optimizing the spatial targeting accuracy during radiotherapy and surgical resection across clinical management of nasopharyngeal carcinoma (NPC). However, the clinical application of photodynamic therapy (PDT) is impeded by the suboptimal reactive oxygen species (ROS) generation efficiency and inadequate visualization of redox procedure. In this study, we developed a theranostic platform HSF, featuring integrated tumor-specific near-infrared (NIR) fluorescence imaging and photodynamic ROS generation for real time monitoring and targeted radiotherapy of solid malignancies for NPC. Mechanistically, HSF was initially activated by the elevated glutathione (GSH) levels in the tumor microenvironment, which concomitantly turned on its NIR fluorescence and photodynamic properties. The resulting NIR fluorescence allowed for tumor visualization, while the PDT-triggered oxidative stress further consumed intracellular GSH, thereby ultimately inducing ferroptosis. In NPC cell-derived xenograft models, HSF demonstrated exceptional biocompatibility and effective in vivo retention. This multifunctional photosensitizer enabled precise radiotherapy navigation via real time fluorescent monitoring and ferroptosis-mediated therapeutic mechanisms, offering a transformative approach for real time visualization-guided NPC therapy.

Indexed as

GlutathioneNasopharyngeal CarcinomaNasopharyngeal NeoplasmsPhotochemotherapyRadiation-Sensitizing AgentsReactive Oxygen SpeciesAnimalsCell Line, TumorHumansInfrared RaysMiceMice, Inbred BALB CMice, NudePhotosensitizing AgentsGlutathionePhotosensitizing AgentsRadiation-Sensitizing AgentsReactive Oxygen Speciesferroptosisnasopharyngeal carcinomaNIR fluorescence imagingphotodynamic therapyradiotherapy

Identifiers

PMID42605989
PMCPMC13533241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.